Glucocorticoid-induced osteoporosis in growing mice is not prevented by simultaneous intermittent PTH treatment

Calcified Tissue International

Volumn 85, Issue 6, 2009, Pages 530-537

  Postnov, Andrei ^a,b   De Schutter, Tineke ^a   Sijbers, Jan ^a   Karperien, Marcel ^c   De Clerck, Nora ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b LEBEDEV PHYSICAL INSTITUTE   (Russian Federation)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Animal model; Bone architecture structure; Osteoporosis; Parathyroid hormone; Parathyroid hormone related peptide; Peptide hormone

Indexed keywords

DEXAMETHASONE; PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE FRAGILITY; BONE MINERALIZATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORTICAL BONE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG INTERMITTENT THERAPY; FEMALE; FEMUR; GROWTH RETARDATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; LUMBAR VERTEBRA; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TRABECULAR BONE;

ANIMALS; BONE DENSITY; FEMALE; FEMUR; GLUCOCORTICOIDS; GROWTH DISORDERS; MICE; MICE, INBRED STRAINS; OSTEOPOROSIS; PARATHYROID HORMONE; X-RAY MICROTOMOGRAPHY;

EID: 72449189569     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-009-9301-3     Document Type: Article

References (31)

1. D Chrysis EM Ritzen L Savendahl 2003 Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes J Endocrinol 176 331 337 10.1677/joe.0.1760331 1:CAS:528: DC%2BD3sXis1amtrg%3D 12630918 (Pubitemid 36410417)
2. G Silvestrini P Ballanti FR Patacchioli P Mocetti GR Di BM Wedard L Angelucci E Bonucci 2000 Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone Bone 26 33 42 10.1016/S8756-3282(99) 00245-8 1:CAS:528:DyaK1MXnvFelsbg%3D 10617155
3. BC van der Eerden M Karperien JM Wit 2003 Systemic and local regulation of the growth plate Endocr Rev 24 782 801 10.1210/er.2002-0033 14671005 (Pubitemid 38067699)
4. NE Lane S Sanchez GW Modin HK Genant E Pierini CD Arnaud 1998 Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial J Clin Invest 102 1627 1633 10.1172/JCI3914 1:CAS:528:DyaK1cXmvVynsL0%3D 9788977
5. RS Weinstein RL Jilka AM Parfitt SC Manolagas 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone J Clin Invest 102 274 282 10.1172/JCI2799 1:CAS:528:DyaK1cXkslOktrc%3D 9664068
6. CA O'Brien D Jia LI Plotkin T Bellido CC Powers SA Stewart SC Manolagas RS Weinstein 2004 Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength Endocrinology 145 1835 1841 10.1210/en.2003-0990 14691012 (Pubitemid 38402392)
7. E Canalis G Mazziotti A Giustina JP Bilezikian 2007 Glucocorticoid- induced osteoporosis: pathophysiology and therapy Osteoporos Int 18 1319 1328 10.1007/s00198-007-0394-0 1:CAS:528:DC%2BD2sXhtVagurrN 17566815 (Pubitemid 47389469)
8. RS Weinstein JR Chen CC Powers SA Stewart RD Landes T Bellido RL Jilka AM Parfitt SC Manolagas 2002 Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids J Clin Invest 109 1041 1048 1:CAS:528:DC%2BD38XivFKjsLs%3D 11956241
9. E Canalis AM Delany 2002 Mechanisms of glucocorticoid action in bone Ann NY Acad Sci 966 73 81 10.1111/j.1749-6632.2002.tb04204.x 1:CAS:528: DC%2BD38XlvVWmsbk%3D 12114261
10. TP Van Staa 2006 The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis Calcif Tissue Int 79 129 137 10.1007/s00223-006-0019-1 1:CAS:528:DC%2BD28XpvFalsbk%3D 16969593 (Pubitemid 44440440)
11. G Balooch W Yao JW Ager M Balooch RK Nalla AE Porter RO Ritchie NE Lane 2007 The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of clucocorticoids Arthritis Rheum 56 3726 3737 10.1002/art.22976 1:CAS:528:DC%2BD2sXhsVSkt7nK 17968931 (Pubitemid 350100706)
12. JM Alexander I Bab S Fish R Muller T Uchiyama G Gronowicz M Nahounou Q Zhao DW White M Chorev D Gazit M Rosenblatt 2001 Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice J Bone Miner Res 16 1665 1673 10.1359/jbmr.2001.16.9.1665 1:CAS:528:DC%2BD3MXmvV2qsLg%3D 11547836
13. SA Gittens GR Wohl RF Zernicke JR Matyas P Morley H Uludag 2004 Systemic bone formation with weekly PTH administration in ovariectomized rats J Pharm Pharm Sci 7 27 37 1:CAS:528:DC%2BD2cXktFGit7o%3D 15144732
14. W Yao Z Cheng A Pham C Busse EA Zimmerman RO Ritchie NE Lane 2008 Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization Arthritis Rheum 58 3485 3497 10.1002/art.23954 1:CAS:528:DC%2BD1cXhsV2hs7bJ 18975341
15. KG Saag E Shane S Boonen F Marin DW Donley KA Taylor GP Dalsky R Marcus 2007 Teriparatide or alendronate in glucocorticoid-induced osteoporosis N Engl J Med 357 2028 2039 10.1056/NEJMoa071408 1:CAS:528:DC%2BD2sXhtlWis7rP 18003959 (Pubitemid 350106710)
16. SC van Buul-Offers JJ Smink R Gresnigt N Hamers J Koedam M Karperien 2005 Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation Pediatr Nephrol 20 335 341 10.1007/s00467-004-1690-y 15688232 (Pubitemid 40309939)
17. JH Waarsing JS Day JC van der Linden AG Ederveen C Spanjers N De Clerck A Sasov JA Verhaar H Weinans 2004 Detecting and tracking local changes in the tibiae of individual rats: a novel method to analyse longitudinal in vivo micro-CT data Bone 34 163 169 10.1016/j.bone.2003.08.012 1:STN:280: DC%2BD2c%2FltVeqtA%3D%3D 14751574 (Pubitemid 38142445)
18. De Clerck N, Postnov A (2007) High resolution X-ray microtomography: applications in biomedical research. In: Tavitian B, Leroy-Willig A, Ntziachristos V (eds) International textbook of in vivo imaging in vertebrates. Wiley, London, pp 57-77
19. R Rooman G Koster R Bloemen R Gresnigt SC van Buul-Offers 1999 The effect of dexamethasone on body and organ growth of normal and IGF-II transgenic mice J Endocrinol 163 543 552 10.1677/joe.0.1630543 1:CAS:528:DC%2BD3cXks1amsQ%3D%3D 10588828
20. JJ Smink MG Gresnigt N Hamers JA Koedam R Berger SC Van Buul-Offers 2003 Short-term glucocorticoid treatment of prepubertal mice decreases growth and IGF-I expression in the growth plate J Endocrinol 177 381 388 10.1677/joe.0.1770381 1:CAS:528:DC%2BD3sXkslCgtbw%3D 12773118 (Pubitemid 36722293)
21. Mohan S, Kutilek S, Zhang C, Shen HG, Kodama Y, Srivastava AK, Wergedal JE, Beamer WG, Baylink DJ (2000) Comparison of bone formation responses to parathyroid hormone (1-34), (1-31), and (2-34) in mice. Bone 27:471-478
22. N Miyakoshi Y Kasukawa TA Linkhart DJ Baylink S Mohan 2001 Evidence that anabolic effects of PTH on bone require IGF-I in growing mice Endocrinology 142 4349 4356 10.1210/en.142.10.4349 1:CAS:528:DC%2BD3MXnt1ertL8%3D 11564695 (Pubitemid 32907063)
23. LA Feldkamp LC Davis JW Kress 1984 Practical cone-beam algorithm J Opt Soc Am A1 612 619 10.1364/JOSAA.1.000612
24. A Postnov A Vinogradov D Van Dyck SV Saveliev NM De Clerck 2003 Quantitative analysis of bone mineral content by X-ray microtomography Physiol Meas 24 165 178 10.1088/0967-3334/24/1/312 1:STN:280:DC%2BD3s7it1Wksw%3D%3D 12636194 (Pubitemid 36330463)
25. 2 and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats Calcif Tissue Int 83 121 128 10.1007/s00223-008- 9146-1 1:CAS:528:DC%2BD1cXhtVyisr7L 18543014
26. F McLaughlin J Mackintosh BP Hayes A McLaren IJ Uings P Salmon J Humphreys E Meldrum SN Farrow 2002 Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers Bone 30 924 930 10.1016/S8756-3282(02)00737-8 1:CAS:528: DC%2BD38XktFynt7k%3D 12052464 (Pubitemid 34616024)
27. S Ikeda Y Morishita H Tsutsumi M Ito A Shiraishi S Arita S Akahoshi K Narusawa T Nakamura 2003 Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs Bone 33 779 787 10.1016/S8756-3282(03) 00263-1 1:CAS:528:DC%2BD3sXovVemtrg%3D 14623053 (Pubitemid 37393489)
28. RL Jilka 2007 Molecular and cellular mechanisms of the anabolic effect of intermittent PTH Bone 40 1434 1446 10.1016/j.bone.2007.03.017 1:CAS:528:DC%2BD2sXlsF2ntLY%3D 17517365 (Pubitemid 46756429)
29. J Fox MA Miller MK Newman AF Metcalfe CH Turner RR Recker SY Smith 2006 Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength Calcif Tissue Int 79 262 272 10.1007/s00223-006-0108-1 1:CAS:528:DC%2BD28XhtFGjs7%2FK 16969596 (Pubitemid 44673720)
30. H Oxlund G Ortoft JS Thomsen CC Danielsen C Ejersted TT Andreassen 2006 The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment Bone 39 244 252 10.1016/j.bone.2006.01.142 1:CAS:528: DC%2BD28Xls1ejt7o%3D 16503210 (Pubitemid 43851361)
31. E Knopp N Troiano M Bouxsein BH Sun K Lostritto C Gundberg J Dziura K Insogna 2005 The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone Endocrinology 146 1983 1990 10.1210/en.2004-0770 1:CAS:528:DC%2BD2MXis1yqurk%3D 15618351 (Pubitemid 40396908)